KIR2DL2 (Lirilumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607888

The Human Monoclonal anti-KIR2DL2 (Lirilumab Biosimilar) antibody has been validated for FACS. It is suitable to detect KIR2DL2 (Lirilumab Biosimilar) in samples from Human.

Quick Overview for KIR2DL2 (Lirilumab Biosimilar) antibody (Biotin) (ABIN7607888)

Target: KIR2DL2 (Lirilumab Biosimilar)

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This KIR2DL2 (Lirilumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS)

Product Details anti-KIR2DL2 (Lirilumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-KIR2DL2(lirilumab biosimilar) mAb

Isotype: IgG4

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for KIR2DL2 (Lirilumab Biosimilar)

Target: KIR2DL2 (Lirilumab Biosimilar)

Alternative Name: lirilumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD158b,CD158B1,NKAT-6,NKAT6,p58.2
Synonyms Antibody:BMS-986015, IPH2102